YouTube creator Gossip Goblin brings AI-assisted feature “Gods Don’t Give Gifts” to U.S. theaters, testing whether online fandom can drive box office.
In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company, and more.
With an FDA panel expected to recommend legal production of as many as seven peptides this week, compounding pharmacies and telehealth companies are preparing for the coming bonanza.
More than 600,000 police reports have been written with help from Axon’s AI tools. Public records obtained by Forbes show that they can introduce errors that cops have to spend time editing out.
Chinese open-source models like Kimi and Deepseek are now dominant AI tools. American startups like Thinking Machines, Reflection AI and now Poolside are trying to challenge that.
Khosla Ventures is putting $30 million into Twenty, a cyber startup that uses AI models from Anthropic and OpenAI to run hacking campaigns for the Department of War.
Some analysts warn that the U.S. market is too competitive. But David Vélez has built a $13 billion fortune proving the naysayers wrong.
This week’s Current Climate newsletter also looks at how the U.S. EV market is about to get quirkier and the bipartisan appeal of recycling.
Founders who were working on neural-signal headphones and viral presentation builders are starting over in a high-stakes race for survival and revenue.
Forbes expert healthcare contributors explain the growing cyclosporiasis outbreak, how the parasite spreads, symptoms to watch for and how you can protect yourself.